Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision, and tingling.
The report details the trend, potential and market size of Stem Cell Therapy for Multiple Sclerosis market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Stem Cell Therapy for Multiple Sclerosismarket, defines the market attractiveness level of Stem Cell Therapy for Multiple Sclerosis market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Stem Cell Therapy for Multiple Sclerosis industry, describes the types of Stem Cell Therapy for Multiple Sclerosis market, the applications of major players and the market size, and deeply analyzes the current situation of the global Stem Cell Therapy for Multiple Sclerosis market and the development prospects and opportunities of Stem Cell Therapy for Multiple Sclerosis industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Stem Cell Therapy for Multiple Sclerosis market in Chapter 13.
By Player:
Celgene Cellular Therapeutics
Athersys
American CryoStem
Cell Cure Neurosciences
MEDIPOST Co, Ltd
By Type:
Intravenous
Intracerebroventricular
By End-User:
Relapsing-Remitting Multiple Sclerosis (RRMS)
Primary Progressive Multiple Sclerosis (PPMS)
Secondary Progressive Multiple Sclerosis (SPMS)
Progressive Relapsing Multiple Sclerosis (PRMS)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Stem Cell Therapy for Multiple Sclerosis Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Stem Cell Therapy for Multiple Sclerosis Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Stem Cell Therapy for Multiple Sclerosis Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Stem Cell Therapy for Multiple Sclerosis Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Stem Cell Therapy for Multiple Sclerosis Market Analysis and Outlook to 2022
-
7.1 Global Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.2 United States Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.3 Europe Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.4 China Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.5 Japan Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.6 India Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
-
7.7 South Korea Stem Cell Therapy for Multiple Sclerosis Consumption (2017-2022)
8 Region and Country-wise Stem Cell Therapy for Multiple Sclerosis Market Analysis and Outlook to 2028
-
8.1 Global Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.2 United States Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.3 Europe Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.4 China Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.5 Japan Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.6 India Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
-
8.7 South Korea Stem Cell Therapy for Multiple Sclerosis Consumption Forecast (2022-2028)
9 Global Stem Cell Therapy for Multiple Sclerosis Market Outlook by Types and Applications to 2022
-
9.1 Global Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Intracerebroventricular Consumption and Growth Rate (2017-2022)
-
9.2 Global Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Relapsing-Remitting Multiple Sclerosis (RRMS) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Primary Progressive Multiple Sclerosis (PPMS) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Secondary Progressive Multiple Sclerosis (SPMS) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Progressive Relapsing Multiple Sclerosis (PRMS) Consumption and Growth Rate (2017-2022)
10 Global Stem Cell Therapy for Multiple Sclerosis Market Outlook by Types and Applications to 2028
-
10.1 Global Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Intracerebroventricular Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Relapsing-Remitting Multiple Sclerosis (RRMS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Primary Progressive Multiple Sclerosis (PPMS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Secondary Progressive Multiple Sclerosis (SPMS) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Progressive Relapsing Multiple Sclerosis (PRMS) Consumption Forecast and Growth Rate (2022-2028)
11 Global Stem Cell Therapy for Multiple Sclerosis Import and Export Analysis (Top 5 Countries)
-
11.1 Global Stem Cell Therapy for Multiple Sclerosis Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Stem Cell Therapy for Multiple Sclerosis Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Stem Cell Therapy for Multiple Sclerosis Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Stem Cell Therapy for Multiple Sclerosis Market Competitive Analysis
-
14.1 Celgene Cellular Therapeutics
-
14.1.1 Celgene Cellular Therapeutics Company Details
-
14.1.2 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product and Service
-
14.2 Athersys
-
14.2.1 Athersys Company Details
-
14.2.2 Athersys Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Athersys Stem Cell Therapy for Multiple Sclerosis Product and Service
-
14.3 American CryoStem
-
14.3.1 American CryoStem Company Details
-
14.3.2 American CryoStem Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 American CryoStem Stem Cell Therapy for Multiple Sclerosis Product and Service
-
14.4 Cell Cure Neurosciences
-
14.4.1 Cell Cure Neurosciences Company Details
-
14.4.2 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product and Service
-
14.5 MEDIPOST Co, Ltd
-
14.5.1 MEDIPOST Co, Ltd Company Details
-
14.5.2 MEDIPOST Co, Ltd Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 MEDIPOST Co, Ltd Stem Cell Therapy for Multiple Sclerosis Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Stem Cell Therapy for Multiple Sclerosis
-
Figure Stem Cell Therapy for Multiple Sclerosis Picture
-
Table Global Stem Cell Therapy for Multiple Sclerosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Stem Cell Therapy for Multiple Sclerosis Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Stem Cell Therapy for Multiple Sclerosis Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Stem Cell Therapy for Multiple Sclerosis Consumption by Country (2017-2022)
-
Figure United States Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Table Europe Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure China Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Japan Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure India Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure South Korea Stem Cell Therapy for Multiple Sclerosis Consumption and Growth Rate (2017-2022)
-
Figure Global Stem Cell Therapy for Multiple Sclerosis Consumption Forecast by Country (2022-2028)
-
Figure United States Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Stem Cell Therapy for Multiple Sclerosis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Consumption and Growth Rate (2017-2022)
-
Figure Global Intracerebroventricular Consumption and Growth Rate (2017-2022)
-
Figure Global Relapsing-Remitting Multiple Sclerosis (RRMS) Consumption and Growth Rate (2017-2022)
-
Figure Global Primary Progressive Multiple Sclerosis (PPMS) Consumption and Growth Rate (2017-2022)
-
Figure Global Secondary Progressive Multiple Sclerosis (SPMS) Consumption and Growth Rate (2017-2022)
-
Figure Global Progressive Relapsing Multiple Sclerosis (PRMS) Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intracerebroventricular Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Relapsing-Remitting Multiple Sclerosis (RRMS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Primary Progressive Multiple Sclerosis (PPMS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Secondary Progressive Multiple Sclerosis (SPMS) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Progressive Relapsing Multiple Sclerosis (PRMS) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Stem Cell Therapy for Multiple Sclerosis Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Stem Cell Therapy for Multiple Sclerosis Export by Region (Top 5 Countries) (2017-2028)
-
Table Celgene Cellular Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Cellular Therapeutics Stem Cell Therapy for Multiple Sclerosis Product and Service
-
Table Athersys (Foundation Year, Company Profile and etc.)
-
Table Athersys Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Athersys Stem Cell Therapy for Multiple Sclerosis Product and Service
-
Table American CryoStem (Foundation Year, Company Profile and etc.)
-
Table American CryoStem Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table American CryoStem Stem Cell Therapy for Multiple Sclerosis Product and Service
-
Table Cell Cure Neurosciences (Foundation Year, Company Profile and etc.)
-
Table Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Cure Neurosciences Stem Cell Therapy for Multiple Sclerosis Product and Service
-
Table MEDIPOST Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table MEDIPOST Co, Ltd Stem Cell Therapy for Multiple Sclerosis Sales, Price, Value and Gross Profit (2017-2022)
-
Table MEDIPOST Co, Ltd Stem Cell Therapy for Multiple Sclerosis Product and Service
-
